GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
895
c/glp1science·posted 7 months ago by u/farid_kuipers

21 months in and pharmacology is still the thing I get wrong

Question Clean Column ×9

Genuinely asking, not being difficult.

Everyone in c/meta repeats that half-life is important. I believe it, but I have never seen anyone show why, and when I search I get 10 threads of people agreeing with each other.

Is there a paper? Is there a measurement? Or is this one of those things that is true because it has been repeated since 2023?

I am not trying to be the "source?" guy. I would just like a source.

1,083 up / 188 down85% upvoted33 commentsid xnggou31 Dec 2025

33 comments

24 in this archive, depth 4

best — the order this archive was captured in

u/gastric_emptying_g0 points·6 months ago

glucagon-receptor contribution is half-life for dual and triple agonism

replysharereportpermalink
u/split_dose_sceptic-35 points·6 months ago

glucagon-receptor contribution is half-life for dual and triple agonism

Yes, exactly this, and it is the bit that took me 9 weeks to accept.

replysharereportpermalink
u/asks_dumb_questions1 point·6 months ago

do not extrapolate rodent data to human dosing without saying so

replysharereportpermalink
[removed]1 point·6 months ago

[removed by moderator]

replysharereportpermalink
u/ireland_drugs_pay1 point·6 months ago

Which paper are you quoting?

replysharereportpermalink
u/plain_titration1 point·6 months ago

the half-life is pharmacology, affects steady state timing

replysharereportpermalink
u/ferran_dahlberg0 points·7 months ago

Rodent data is rodent data. Dose scaling is not linear and the models tell you what to investigate, not what to expect.

replysharereportpermalink
u/devils_advocate_d59 points·6 months ago

Is that mechanism or speculation?

replysharereportpermalink
u/nhs_waitlist_nUK15 points·6 months ago

receptor distribution matters, GLP-1 is not everywhere

replysharereportpermalink
u/devils_advocate_d12 points·6 months ago

receptor distribution matters, GLP-1 is not everywhere

Adding to this: pharmacology is doing more work than the comment implies.

replysharereportpermalink
u/marisol_kravchenko20 points·6 months ago·edited

the half-life is half-life, affects steady state timing

replysharereportpermalink
u/emil_agyeman14 points·6 months ago

central appetite signalling is real but people overweight it

replysharereportpermalink
u/noor_hovland7 points·6 months ago

mechanistic speculation is welcome if flaired as speculation

replysharereportpermalink
u/the_poster_in_question_202644 points·6 months ago

Is that mechanism or speculation?

Counter-anecdote: opposite result, same dose. Which mostly tells us the variance is huge.

replysharereportpermalink
u/emil_agyeman17 points·6 months ago

The incretin literature is interesting but rodent models do not scale linearly to human dosing.

replysharereportpermalink
u/farid_kuipersOP6 points·6 months ago

amylin is not GLP-1, posts conflating them get corrected

replysharereportpermalink
u/niels_roos42 points·6 months ago

This is the "correlation is mechanism" thing again. You changed three variables at once.

replysharereportpermalink
u/aleksi_eriksen14 points·6 months ago

mechanistic speculation is welcome if flaired as speculation

replysharereportpermalink
u/osman_eriksen10 points·6 months ago

cite the paper: journal, year, first author, links optional

replysharereportpermalink
u/camila_mensa19 points·6 months ago

The incretin literature is interesting but rodent models do not scale linearly to human dosing.

replysharereportpermalink
u/bastian_eriksen16 points·6 months ago·edited

Rodent, human, or in vitro?

replysharereportpermalink
u/aksel_palacios11 points·6 months ago

Small correction: the trial was 22 weeks, not 31. Does not change your point but people will quote it.

replysharereportpermalink
u/marisol_kravchenko3 points·6 months ago

Is that mechanism or speculation?

replysharereportpermalink
u/aa_analysis_andy2 points·6 months ago

amylin is not GLP-1, posts conflating them get corrected

replysharereportpermalink
Permalinked branches
Deep branches get their own page so a single reply chain can be linked and read on its own.
About c/glp1science

The mechanism layer: incretin physiology, receptor distribution, gastric emptying, central appetite signalling, glucagon-receptor contribution, amylin co-agonism, and the pharmacokinetics that make weekly dosing possible. Papers get cited by journal and year or they get a [needs source] reply.

50kmembers
95submissions
Oct 2023created
submissions / month, last year
Sponsored

PeptideMeter Analytics

Independent testing plus vendor-level trend data. Community-funded, unaffiliated.

peptidemeter.com
c/glp1science rules
  1. Cite the paper: journal, year, first author. Links optional, citation mandatory.
  2. Mechanistic speculation is welcome if flaired as speculation.
  3. No extrapolating rodent data to human dosing without saying that is what you are doing.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Moderators
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.